Datametrex Secures Rights To New PCR Test Kit
Datametrex AI (TSXV: DM) continues to develop out its healthcare division focused on COVID-19 testing. The firm this morning revealed
Read moreDatametrex AI (TSXV: DM) continues to develop out its healthcare division focused on COVID-19 testing. The firm this morning revealed
Read moreFollowing the launch of its Medi-Call mobile app just days ago, Datametrex AI (TSXV: DM) this morning had another announcement
Read moreToday on the Daily Dive, we are joined by Marshall Gunter, CEO of Datametrex AI. Within, Marshall discusses the recent
Read moreDatametrex AI (TSXV: DM) appears to be just a step away from securing a major contract in Canada. The company
Read moreDatametrex AI (TSXV: DM) is one step closer to offering a full service telemedicine app. The company this morning indicated
Read moreDatametrex AI (TSXV: DM) showed its cards this morning without formally naming names in its latest development. The firm has
Read moreDatametrex AI (TSXV: DM) keeps grinding out its operations in South Korea. The firm this morning announced another contract in
Read moreIn a rare move within the small cap space, Datametrex AI (TSXV: DM) has provided an update on guidance provided
Read moreDatametrex AI (TSXV: DM) issued a brief press release this morning, indicating it has secured two additional contracts. The contracts
Read moreDatametrex AI (TSXV: DM) continues to deliver on its healthcare operation as it pertains to testing for COVID-19. The company
Read more